EUVIMEDEUVIMED entdecken
Crossref

Cannabidiol attenuates periodontal inflammation through inhibiting TLR4 / NF‐κB pathway

Hao Chen, Yaqi Liu, Sijing Yu, Cheng Li, Bo Gao, Xuedong Zhou

Journal of Periodontal Research · 2023

DOI: 10.1111/jre.13118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Periodontal Research, 2023. Verfasst von Hao Chen und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Cannabidiol, Periodontitis. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Department of Science and Technology of Sichuan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Objective Periodontitis is a chronic inflammatory disease involving soft and hard tissue destruction in the periodontal region. Cannabidiol (CBD) is a natural compound isolated from cannabis, which has the effect of inhibiting inflammation. However, the role of CBD in periodontitis remains unclear. The aim of this study was to investigate the anti‐inflammatory effects and osteoprotective actions of CBD in periodontitis and its molecular mechanisms. Materials and Methods After establishing the rat periodontitis model by ligatures, the specimens were processed for morphometric analysis by Micro‐CT. The gingival tissues were collected, and the levels of TNF‐α, IL‐1β, and TLR4 were measured by enzyme‐linked immunosorbent assay. LPS was used to induce the inflammatory response of human periodontal ligament cells (hPDLCs) in vitro. QPCR and western blot were carried out to detect the expression of related inflammatory cytokines and signaling pathways.

Results

Cannabidiol significantly inhibits bone loss in experimental rat periodontitis models. CBD downregulated the pro‐inflammatory mediator TNF‐α, related to the decrease of TLR4 protein expression. Overexpression of TNF‐α and TLR4 caused by LPS in hPDLCs. CBD inactivated the TLR4/NF‐κB signaling pathway by inhibiting TLR‐4 expression and p65 NF‐κB phosphorylation. CBD can be considered as a therapeutic agent for periodontitis.

Conclusion

Our study demonstrated that CBD attenuates ligature‐induced periodontitis in rats and LPS‐induced inflammation in hPDLCs by inhibiting TLR4/NF‐κB pathway activation. It indicates that topical CBD application is effective in treating periodontitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CannabidiolPeriodontitisHumansRatsAnimalsNF-kappa BTumor Necrosis Factor-alphaLipopolysaccharidesToll-Like Receptor 4Inflammation

Stichwörter der Autor:innen

LPSNF-ΚbTLR4cannabidiolperiodontitis

Substanzen

NF-kappa BCannabidiolTumor Necrosis Factor-alphaLipopolysaccharidesToll-Like Receptor 4TLR4 protein, human

Autor:innen und Institutionen

  • State Key Laboratory of Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.
  • Yunnan Hempson Bio-Tech Co., Ltd., Zhaotong, China.
  • Department of Cariology and Endodontics, West China Hospital of Stomatology, Sichuan University, Chengdu, China.

Förderung

  • Department of Science and Technology of Sichuan Province

Zitieren

APA

Chen, H., Liu, Y., Yu, S., Li, C., Gao, B., & Zhou, X. (2023). Cannabidiol attenuates periodontal inflammation through inhibiting TLR4 / NF‐κB pathway. Journal of Periodontal Research. https://doi.org/10.1111/jre.13118

Vancouver

Chen H, Liu Y, Yu S, Li C, Gao B, Zhou X. Cannabidiol attenuates periodontal inflammation through inhibiting TLR4 / NF‐κB pathway. Journal of Periodontal Research. 2023. doi:10.1111/jre.13118

BibTeX
@article{Chen2023,
  author = {Chen, Hao and Liu, Yaqi and Yu, Sijing and Li, Cheng and Gao, Bo and Zhou, Xuedong},
  title = {Cannabidiol attenuates periodontal inflammation through inhibiting TLR4 / NF‐κB pathway},
  journal = {Journal of Periodontal Research},
  year = {2023},
  doi = {10.1111/jre.13118}
}
Kostenlos starten →